Nasal Spray Market is anticipated to grow at a significant CAGR during the forecast period. Nasal spray is a liquid form of concentrated medicine that is dispensed through a compact container/bottle into the nose for the treatment of the nasal congestion problem. The active ingredient’s intended action can be local or systemic in nature. Nasal spray sprays are designed to be deposited in the nasal or pharyngeal region. The rising prevalence of asthma and COPD, as well as the low cost of these sprays are propelling the market growth. Asthma is the most common chronic condition among children globally, as per the World Health Organization (WHO) research published in 2019. Asthma affected around 235 million people across the globe in 2019. Low- and lower-middle-income nations account for more than 80% of asthma-related mortalities.
The risk factor for developing asthma includes inhaled substances and particles that create allergic reactions or irritate the airways whereas risk factor leading to the cause of COPD includes tobacco smoke or second-hand smoke, exposure to indoor or outdoor air pollution, dusts and fumes, and long-term asthma. Furthermore, as per the study conducted by National Health and Planning Commission in 2019, 30 million people in China suffered from asthma and only 28% of the people with asthma have their condition under control. This, in turn, is driving the demand for nasal sprays for the management of asthma and COPD.
Some key players operating in the market include AstraZeneca plc, Novartis International AG, and Teva Pharmaceutical Industries Ltd., among others. These players are eyeing on strengthening their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launch and development in the existing product portfolio, and so on. For instance, in February 2022, Glenmark Ltd. and Canadian biotech firm SaNOtize Research and Development Corp launched its Nitric Oxide Nasal Spray (NONS) under the brand name FabiSpray in India. It can be used for the treatment of adult patients with COVID-19 who have a high risk of progression of the disease.
To Request a Sample of our Report on Nasal Spray Market: https://www.omrglobal.com/request-sample/nasal-spray-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2024-2030
Segment Covered-
- By Product
- By Application
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: AstraZeneca plc, Novartis International AG, and Teva Pharmaceutical Industries Ltd., among others.
Nasal Spray Market Report by Segment
By Product
- Bronchodilators
- Corticosteroids
- Combination
- Decongestant
- Others
By Application
- Asthma
- COPD
- Allergic Rhinitis
- Others
A full Report of Nasal Spray Market is Available @ https://www.omrglobal.com/industry-reports/nasal-spray-market
Nasal Spray Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
